Eribulin mesylate

• Target:

  Apoptosis|||Microtubule Associated

• Related Pathways:

  Apoptosis|||Cytoskeletal Signaling

• Purity:

  >99.99%

• Bioactivity:

  Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.

• Smiles:

  CS (O) (=O) =O.[H][C@@]12CC (=C) [C@] ([H]) (CC[C@@]3 ([H]) C[C@@H] (C) C (=C) [C@@] ([H]) (C[C@]4 ([H]) O[C@H] (C[C@H] (O) CN) [C@H] (OC) [C@@]4 ([H]) CC (=O) C[C@@]4 ([H]) CC[C@]5 ([H]) O[C@@]6 ([H]) [C@@]7 ([H]) O[C@@]8 (C[C@@]7 ([H]) O[C@@]6 ([H]) [C@@] ([H]) (O8) [C@@]5 ([H]) O4) CC1) O3) O2

• Molecular Formula:

  C41H63NO14S

• Molecular Weight:

  826

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  441045-17-6